100 related articles for article (PubMed ID: 17693934)
1. Prevention of injury-induced suppression of T-cell immunity by the CD1d/NKT cell-specific ligand alpha-galactosylceramide.
Tulley JM; Palmer JL; Gamelli RL; Faunce DE
Shock; 2008 Feb; 29(2):269-77. PubMed ID: 17693934
[TBL] [Abstract][Full Text] [Related]
2. Natural killer T cells from interleukin-4-deficient mice are defective in early interferon-gamma production in response to alpha-galactosylceramide.
Togashi Y; Chamoto K; Wakita D; Tsutsumi N; Iwakura Y; Matsubara N; Kitamura H; Nishimura T
Cancer Sci; 2007 May; 98(5):721-5. PubMed ID: 17359285
[TBL] [Abstract][Full Text] [Related]
3. Natural killer T cell activation inhibits hepatitis B virus replication in vivo.
Kakimi K; Guidotti LG; Koezuka Y; Chisari FV
J Exp Med; 2000 Oct; 192(7):921-30. PubMed ID: 11015434
[TBL] [Abstract][Full Text] [Related]
4. Rapid development of a gamma interferon-secreting glycolipid/CD1d-specific Valpha14+ NK1.1- T-cell subset after bacterial infection.
Emoto M; Yoshizawa I; Emoto Y; Miamoto M; Hurwitz R; Kaufmann SH
Infect Immun; 2006 Oct; 74(10):5903-13. PubMed ID: 16988270
[TBL] [Abstract][Full Text] [Related]
5. Invariant NKT cell activation induces neutrophil accumulation and hepatitis: opposite regulation by IL-4 and IFN-γ.
Wang H; Feng D; Park O; Yin S; Gao B
Hepatology; 2013 Oct; 58(4):1474-85. PubMed ID: 23686838
[TBL] [Abstract][Full Text] [Related]
6. Design of natural killer T cell activators: structure and function of a microbial glycosphingolipid bound to mouse CD1d.
Wu D; Zajonc DM; Fujio M; Sullivan BA; Kinjo Y; Kronenberg M; Wilson IA; Wong CH
Proc Natl Acad Sci U S A; 2006 Mar; 103(11):3972-7. PubMed ID: 16537470
[TBL] [Abstract][Full Text] [Related]
7. CD1 expression and CD1-restricted T cell activity in normal and tumour-bearing human liver.
Kenna T; O'Brien M; Hogan AE; Exley MA; Porcelli SA; Hegarty JE; O'Farrelly C; Doherty DG
Cancer Immunol Immunother; 2007 Apr; 56(4):563-72. PubMed ID: 16924493
[TBL] [Abstract][Full Text] [Related]
8. Ox-LDL-induced CD80
Wang Y; Zou Y; Jiang Q; Li W; Chai X; Zhao T; Liu S; Yuan Z; Yu C; Wang T
Am J Physiol Cell Physiol; 2024 Jun; 326(6):C1563-C1572. PubMed ID: 38586879
[TBL] [Abstract][Full Text] [Related]
9. Activation of CD1d-restricted natural killer T cells can inhibit cancer cell proliferation during chemotherapy by promoting the immune responses in murine mesothelioma.
Wu L; Yun Z; Tagawa T; De la Maza L; Wu MO; Yu J; Zhao Y; de Perrot M
Cancer Immunol Immunother; 2014 Dec; 63(12):1285-96. PubMed ID: 25183171
[TBL] [Abstract][Full Text] [Related]
10. Natural killer T-cell autoreactivity leads to a specialized activation state.
Wang X; Chen X; Rodenkirch L; Simonson W; Wernimont S; Ndonye RM; Veerapen N; Gibson D; Howell AR; Besra GS; Painter GF; Huttenlocher A; Gumperz JE
Blood; 2008 Nov; 112(10):4128-38. PubMed ID: 18779390
[TBL] [Abstract][Full Text] [Related]
11. Potent immune-modulating and anticancer effects of NKT cell stimulatory glycolipids.
Chang YJ; Huang JR; Tsai YC; Hung JT; Wu D; Fujio M; Wong CH; Yu AL
Proc Natl Acad Sci U S A; 2007 Jun; 104(25):10299-304. PubMed ID: 17566107
[TBL] [Abstract][Full Text] [Related]
12. Natural killer T cell-mediated antitumor immune responses and their clinical applications.
Seino K; Motohashi S; Fujisawa T; Nakayama T; Taniguchi M
Cancer Sci; 2006 Sep; 97(9):807-12. PubMed ID: 16805854
[TBL] [Abstract][Full Text] [Related]
13. Bacterial glycolipids and analogs as antigens for CD1d-restricted NKT cells.
Wu D; Xing GW; Poles MA; Horowitz A; Kinjo Y; Sullivan B; Bodmer-Narkevitch V; Plettenburg O; Kronenberg M; Tsuji M; Ho DD; Wong CH
Proc Natl Acad Sci U S A; 2005 Feb; 102(5):1351-6. PubMed ID: 15665086
[TBL] [Abstract][Full Text] [Related]
14. The innate immune system recognizes and regulates major histocompatibility complex class I (MHCI) expression on MHCIlow tumor cells.
Rubin B; Riond J; Courtiade L; Roullet N; Gairin JE
Cancer Immun; 2008 Sep; 8():14. PubMed ID: 18783178
[TBL] [Abstract][Full Text] [Related]
15. Crystal structures of mouse CD1d-iGb3 complex and its cognate Valpha14 T cell receptor suggest a model for dual recognition of foreign and self glycolipids.
Zajonc DM; Savage PB; Bendelac A; Wilson IA; Teyton L
J Mol Biol; 2008 Apr; 377(4):1104-16. PubMed ID: 18295796
[TBL] [Abstract][Full Text] [Related]
16. Phase I study of alpha-galactosylceramide-pulsed antigen presenting cells administration to the nasal submucosa in unresectable or recurrent head and neck cancer.
Uchida T; Horiguchi S; Tanaka Y; Yamamoto H; Kunii N; Motohashi S; Taniguchi M; Nakayama T; Okamoto Y
Cancer Immunol Immunother; 2008 Mar; 57(3):337-45. PubMed ID: 17690880
[TBL] [Abstract][Full Text] [Related]
17. Natural immunosurveillance against spontaneous, autochthonous breast cancers revealed and enhanced by blockade of IL-13-mediated negative regulation.
Park JM; Terabe M; Donaldson DD; Forni G; Berzofsky JA
Cancer Immunol Immunother; 2008 Jun; 57(6):907-12. PubMed ID: 18004566
[TBL] [Abstract][Full Text] [Related]
18. The Role of Type I and Type II NKT Cells in Materno-Fetal Immunity.
Miko E; Barakonyi A; Meggyes M; Szereday L
Biomedicines; 2021 Dec; 9(12):. PubMed ID: 34944717
[TBL] [Abstract][Full Text] [Related]
19. Advancements on the Multifaceted Roles of Sphingolipids in Hematological Malignancies.
Raza Y; Atallah J; Luberto C
Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361536
[TBL] [Abstract][Full Text] [Related]
20. Mass Spectrometric Imaging of Ceramide Biomarkers Tracks Therapeutic Response in Traumatic Brain Injury.
Barbacci DC; Roux A; Muller L; Jackson SN; Post J; Baldwin K; Hoffer B; Balaban CD; Schultz JA; Gouty S; Cox BM; Woods AS
ACS Chem Neurosci; 2017 Oct; 8(10):2266-2274. PubMed ID: 28745861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
